Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Papadavid E, Kapniari E, Pappa V, Nikolaou V, et al. Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sezary syndrome with variable CD30 positivity. Br J Dermatol 2021;185:1035-1044.
PMID: 34137025


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016